Research Topics
| B H WolffenbuttelSummaryAffiliation: University Hospital Maastricht Country: The Netherlands Publications
| Collaborators
|
Detail Information
Publications
Comparison of different insulin regimens in elderly patients with NIDDMB H Wolffenbuttel
Department of Internal Medicine, University Hospital Maastricht, The Netherlands
Diabetes Care 19:1326-32. 1996....- [Postprandial glucose peaks in the pathogenesis of cardiovascular disease in diabetes mellitus; implications for metabolic control]B H R Wolffenbuttel
Academisch Ziekenhuis, Afd Endocrinologie, Postbus 5800, 6202 AZ Maastricht
Ned Tijdschr Geneeskd 146:654-8. 2002..People suffering from diabetes are best advised to direct their self control also at the bloodglucose level 1.5-2 h after a meal... - [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2]B H Wolffenbuttel
Academisch Ziekenhuis, Afd Endocrinologie, Postbus 5800, 6202 AZ Maastrict
Ned Tijdschr Geneeskd 145:761-5. 2001.... - RosiglitazoneB H Wolffenbuttel
Dept of Endocrinology and Metabolism, University Hospital Maastricht, P O Box 5800, NL 6202 AZ Maastricht, The Netherlands
Expert Opin Pharmacother 2:467-78. 2001..Additional studies will also explore its long-term effects in sparing beta-cell function and reducing diabetes-related complications and atherosclerosis... - Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patientsB H Wolffenbuttel
University Hospital Maastricht, The Netherlands
Diabet Med 17:40-7. 2000..This study was designed to test the efficacy and safety of low-dose rosiglitazone, a potent, insulin-sensitizing thiazolidinedione, in combination with sulphonylurea in Type 2 diabetic patients... - Repaglinide--a new compound for the treatment of patients with type 2 diabetesB H Wolffenbuttel
Dept of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands
Neth J Med 55:229-34. 1999..Although the overall incidence of hypoglycaemia was similar during use of repaglinide and of sulphonylurea, fewer serious hypoglycaemic episodes were observed in repaglinide-treated patients... - [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications]B H Wolffenbuttel
Afd Endocrinologie, Academisch Ziekenhuis Maastricht
Ned Tijdschr Geneeskd 143:1197-201. 1999..Non of the antihypertensive drugs used (an ACE inhibitor and a beta-blocking agent) offered any advantages over the other... - A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study GroupB H Wolffenbuttel
Department of Endocrinology, University Hospital Maastricht, The Netherlands
Diabetes Care 22:463-7. 1999..This multicenter study was designed to compare the efficacy and safety of this drug with glyburide in a 1-year randomized double-blind study of outpatients with type 2 diabetes... - Beneficial gamma-knife radiosurgery in a patient with Nelson's syndromeB H Wolffenbuttel
Department of Endocrinology, University Hospital Maastricht, The Netherlands
Clin Neurol Neurosurg 100:60-3. 1998..It is concluded that gamma-knife radiosurgery may be a good alternative for patients with Nelson's syndrome who have rapidly recurring disease... - Prognostic factors for successful insulin therapy in subjects with type 2 diabetesB H Wolffenbuttel
Department of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands
Neth J Med 54:63-9. 1999..To assess which factors influence or predict the efficacy of insulin therapy in subjects with type 2 diabetes, who were poorly controlled despite maximal doses of oral glucose lowering agents... - Efficacy and safety of a new cholesterol synthesis inhibitor, atorvastatin, in comparison with simvastatin and pravastatin, in subjects with hypercholesterolemiaB H Wolffenbuttel
Department of Endocrinology and Metabolism, University Hospital Maastricht, Netherlands
Neth J Med 52:131-7. 1998..In a 16-week, multicenter, randomized, open-label cross-over study we compared the efficacy and safety of the new compound atorvastatin for reducing LDL-cholesterol with simvastatin or pravastatin... - Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patientsW A Oranje
Department of Endocrinology and Metabolism, University Hospital Maastricht, Maastricht, The Netherlands
Clin Chim Acta 311:91-4. 2001..Oxidative stress in diabetes increases lipid peroxidation, which stimulates the development of atherosclerosis... - Arteriolar reactivity in conscious diabetic rats: influence of aminoguanidine treatmentF R Crijns
Department of Endocrinology and Metabolism, Cardiovascular Research Institute, University Hospital Maastricht, The Netherlands
Diabetes 47:918-23. 1998..05 vs. untreated control rats). These data indicate that 6 weeks of experimental diabetes is associated with a decreased endothelium-dependent and -independent vasodilatation. AG treatment had no beneficial effect on this disturbance... - Lipid peroxidation in type 2 diabetes: relationship with macrovascular disease?W A Oranje
Dept of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands
Neth J Med 53:61-8. 1998..Macrovascular disease is the leading cause of death in diabetes. The increased risk of atherosclerosis in diabetes may be partly explained by increased lipid peroxidation... - Mechanical properties of mesenteric arteries in diabetic rats: consequences of outward remodelingF R Crijns
Department of Endocrinology and Metabolism, Cardiovascular Research Institute Maastricht, University Hospital Maastricht, 6202 AZ Maastricht, The Netherlands
Am J Physiol 276:H1672-7. 1999..These results indicate that mesenteric small arteries of diabetic rats display eutrophic outward remodeling associated with increased wall tension and circumferential wall stress... - Effects of acarbose (Glucobay) in persons with type 1 diabetes: a multicentre studyJ P Sels
Department of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands
Diabetes Res Clin Pract 41:139-45. 1998..We conclude that acarbose up to 3 x 100 mg/day can be a valuable adjunct to insulin in improving metabolic control in persons with type 1 diabetes... - Miglitol, a new alpha-glucosidase inhibitorJ P Sels
Department of Endocrinology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
Expert Opin Pharmacother 1:149-56. 1999..More long-term data are needed to fully assess to the clinical use of miglitol in these patients... - Pitfall of the accessory spleenJ P Sels
Department of Endocrinology, University Hospital Maastricht, P O Box 5800, 6202 AZ, Maastricht, The Netherlands
Neth J Med 56:153-8. 2000..The insulinoma was identified as such during laparotomy, whereas additional jodo-cholesterol scintigraphy revealed the real nature of the lesion in the patient with Cushing's syndrome. Both patients were operated successfully... - Clinical experience with Sandostatin LAR in patients with acromegalyC A Heijckmann
Department of Endocrinology, University Hospital Maastricht, P.O. Box 5800, NL-6202 AZ Maastricht, The Netherlands
Neth J Med 59:286-91. 2001..In six patients, the dose had to be increased to 30-40 mg monthly because the IGF-1 levels still remained elevated. Sandostatin LAR may be considered a great improvement for the treatment of patients with (symptomatic) acromegaly... - Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid-binding protein content in liver, heart and kidney of the diabetic ratW Engels
Department of Internal Medicine, Maastricht University, The Netherlands
Mol Cell Biochem 192:53-61. 1999..Consequently, it is not likely that dicarboxylic acids are involved in the induction of peroxisome proliferation in the heart... - CETP inhibition in cardiovascular risk management: a critical appraisalR P F Dullaart
University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Eur J Clin Invest 37:90-8. 2007..We propose that low HDL cholesterol in the context of high triglycerides, such as found in type 2 diabetes mellitus, could become an important indication area for this new class of drugs... - Preoperative pharmacological management of phaeochromocytomaA N A van der Horst-Schrivers
Department of Endocrinology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
Neth J Med 64:290-5. 2006..We reviewed the relevant literature on this subject. In addition, we compared the several preoperative treatment protocols of the eight university medical centres in the Netherlands... - Time course of specific AGEs during optimised glycaemic control in type 2 diabetesC J A L Mentink
Department of Human Biology, Faculty of Health Sciences, Maastricht University, Maastricht, The Netherlands
Neth J Med 64:10-6. 2006..This suggests that these specific AGEs are influenced by other factors in addition to overall glycaemia, such as oxidative stress... - Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitusR De Vries
Department of Endocrinology, University Medical Center Groningen, University of Groningen, P O Box 30 001, RB 9700 Groningen, The Netherlands
Diabetologia 49:398-404. 2006..We analysed the relationship between carotid artery intima-media thickness (IMT), an established marker of atherosclerosis, and PLTP activity in diabetic patients and control subjects... - [Missed hyperinsulinaemia in a patient with an insulinoma]R S M E Wouters
afd Interne Geneeskunde, Scheper Ziekenhuis, Boermarkeweg 60, 7824 AA Emmen
Ned Tijdschr Geneeskd 149:944-6. 2005..Therefore new normative values are needed for the newer insulin assays when diagnosing an insulin-producing islet cell tumour. Pro-insulin and C-peptide assays may play a useful role in this... - Do diabetologists recognise self-management problems in their patients?J C Keers
Northern Centre for Healthcare Research, P O Box 196, Groningen 9700 AD, The Netherlands
Diabetes Res Clin Pract 66:157-61. 2004..The aim of this study was to determine whether diabetologists recognise patients' needs for additional intensive multidisciplinary care due to glycaemic and diabetes-related psychosocial difficulties... - Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetesS R Heller
Northern General Hospital, Sheffield S5 7AU, UK
Diabet Med 21:769-75. 2004.... 
Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a)F Hartgens
Netherlands Centre for Doping Affairs, Capelle aan den IJssel, The Netherlands
Br J Sports Med 38:253-9. 2004....- Resource consumption and costs in Dutch patients with type 2 diabetes mellitus. Results from 29 general practicesW K Redekop
Institute for Medical Technology Assessment iMTA, Erasmus University Rotterdam, Rotterdam, The Netherlands
Diabet Med 19:246-53. 2002.... - [The prevalence of the metabolic syndrome in the Netherlands: increased risk of cardiovascular diseases and diabetes mellitus type 2 in one quarter of persons under 60]M B Bos
Rijksinstituut voor Volksgezondheid en Milieu, Centrum voor Voeding en Gezondheid, Bilthoven
Ned Tijdschr Geneeskd 151:2382-8. 2007..To estimate the prevalence of the metabolic syndrome in the Netherlands in two populations in the age category 28-59 years and to compare this with the prevalence of hypercholesterolaemia in these populations...